30 August 2020>: Lab/In Vitro Research
Honokiol Suppression of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastric Cancer Cell Biological Activity and Its Mechanism
Yidan Yan 1ABC , Jianmin Xu 2CDE , Guoxin Mao 3EFG*DOI: 10.12659/MSM.923962
Med Sci Monit 2020; 26:e923962
Figure 6 Human epidermal growth factor receptor 2 (HER2) expression of different groups by cellular immunofluorescence. Control: Untreated cells. Hon-L: Cells treated with low-dose honokiol. Hon-M: Cells treated with middle-dose Hon. Hon-H: Cells treated with high-dose Hon. HER2 expression of different groups by cellular immunofluorescence in NCI-N87 cell line (A) and in OE-19 cell line (B). ** P<0.01, *** P<0.001 compared with control group; # P<0.05 compared with Hon-L group; & P<0.05 compared with Hon-M group.